{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:56:50Z","timestamp":1790881010731,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009517","name":"Universit\u00e9 de Recherche Paris Sciences et Lettres","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009517","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian National Health and Medical Research Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-025-01988-w","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T14:55:35Z","timestamp":1741704935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-9910","authenticated-orcid":false,"given":"Nicolas M.","family":"Viart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6321-3458","authenticated-orcid":false,"given":"Anne-Laure","family":"Renault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5021-7775","authenticated-orcid":false,"given":"S\u00e9verine","family":"Eon-Marchais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9872-6034","authenticated-orcid":false,"given":"Yue","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1755-6307","authenticated-orcid":false,"given":"Laetitia","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0106-1572","authenticated-orcid":false,"given":"Sophia Murat","family":"El Houdigui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0595-7676","authenticated-orcid":false,"given":"Doroth\u00e9e","family":"Le Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7086-2149","authenticated-orcid":false,"given":"Eve","family":"Cavaciuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-8524","authenticated-orcid":false,"given":"Marie-Gabrielle","family":"Dondon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0538-263X","authenticated-orcid":false,"given":"Juana","family":"Beauvallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-5733","authenticated-orcid":false,"given":"Virginie","family":"Raynal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5438-8309","authenticated-orcid":false,"given":"Dominique","family":"Stoppa-Lyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5754-5771","authenticated-orcid":false,"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8820-5550","authenticated-orcid":false,"given":"Nadine","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-9005","authenticated-orcid":false,"given":"Melissa C.","family":"Southey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-4549","authenticated-orcid":false,"given":"Fabienne","family":"Lesueur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"1988_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11:159.","journal-title":"Orphanet J Rare Dis"},{"key":"1988_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/pai.13020","volume":"30","author":"P Amirifar","year":"2019","unstructured":"Amirifar P, Ranjouri MR, Yazdani R, Abolhassani H, Aghamohammadi A. Ataxia-telangiectasia: A review of clinical features and molecular pathology. Pediatr Allergy Immunol. 2019;30:277\u201388.","journal-title":"Pediatr Allergy Immunol"},{"key":"1988_CR3","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1056\/NEJM199112263252602","volume":"325","author":"M Swift","year":"1991","unstructured":"Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia\u2013telangiectasia. N Engl J Med. 1991;325:1831\u20136.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"1988_CR4","first-page":"8","volume":"6","author":"RD Peterson","year":"1992","unstructured":"Peterson RD, Funkhouser JD, Tuck-Muller CM, Gatti RA. Cancer susceptibility in ataxia-telangiectasia. Leukemia. 1992;6(Suppl 1):8\u201313.","journal-title":"Leukemia"},{"key":"1988_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/jnci\/93.2.121","volume":"93","author":"JH Olsen","year":"2001","unstructured":"Olsen JH, Hahnemann JM, Borresen-Dale A-L, Brondum-Nielsen K, Hammarstrom L, Kleinerman R, et al. Cancer in patients with Ataxia-Telangiectasia and in their relatives in the nordic countries. JNCI J Natl Cancer Inst. 2001;93:121\u20137.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1988_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","volume":"128","author":"R Micol","year":"2011","unstructured":"Micol R, Ben Slama L, Suarez F, Le Mignot L, Beaut\u00e9 J, Mahlaoui N, et al. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol. 2011;128:382\u2013e3891.","journal-title":"J Allergy Clin Immunol"},{"key":"1988_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","volume":"33","author":"F Suarez","year":"2015","unstructured":"Suarez F, Mahlaoui N, Canioni D, Andriamanga C, Dubois d\u2019Enghien C, Brousse N, et al. Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French National registry of primary immune deficiencies. J Clin Oncol. 2015;33:202\u20138.","journal-title":"J Clin Oncol"},{"key":"1988_CR8","doi-asserted-by":"publisher","first-page":"e26073","DOI":"10.1016\/j.heliyon.2024.e26073","volume":"10","author":"H Lindahl","year":"2024","unstructured":"Lindahl H, Svensson E, Danielsson A, Puschmann A, Svenningson P, Tesi B, et al. The clinical spectrum of ataxia telangiectasia in a cohort in Sweden. Heliyon. 2024;10:e26073.","journal-title":"Heliyon"},{"key":"1988_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ng1837","volume":"38","author":"A Renwick","year":"2006","unstructured":"The Breast Cancer Susceptibility Collaboration (UK), Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006;38:873\u20135.","journal-title":"Nat Genet"},{"key":"1988_CR10","first-page":"573","volume":"39","author":"M Swift","year":"1986","unstructured":"Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT. The incidence and gene frequency of ataxia-telangiectasia in the united States. Am J Hum Genet. 1986;39:573\u201383.","journal-title":"Am J Hum Genet"},{"key":"1988_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"384","author":"L Dorling","year":"2021","unstructured":"Breast Cancer Association Consortium, Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, Luccarini C, et al. Breast Cancer risk Genes \u2014 Association analysis in more than 113,000 women. N Engl J Med. 2021;384:428\u201339.","journal-title":"N Engl J Med"},{"key":"1988_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"384","author":"C Hu","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, et al. A Population-Based study of genes previously implicated in breast Cancer. N Engl J Med. 2021;384:440\u201351.","journal-title":"N Engl J Med"},{"key":"1988_CR13","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PDP, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, et al. Gene-Panel sequencing and the prediction of Breast-Cancer risk. N Engl J Med. 2015;372:2243\u201357.","journal-title":"N Engl J Med"},{"key":"1988_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ajhg.2009.08.018","volume":"85","author":"SV Tavtigian","year":"2009","unstructured":"Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, et al. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast Cancer. Am J Hum Genet. 2009;85:427\u201346.","journal-title":"Am J Hum Genet"},{"key":"1988_CR15","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/ijc.31921","volume":"144","author":"E Girard","year":"2019","unstructured":"Girard E, Eon-Marchais S, Olaso R, Renault A, Damiola F, Dondon M, et al. Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing. Int J Cancer. 2019;144:1962\u201374.","journal-title":"Int J Cancer"},{"key":"1988_CR16","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/1535-7163.MCT-15-0945","volume":"15","author":"M Choi","year":"2016","unstructured":"Choi M, Kipps T, Kurzrock R. ATM mutations in cancer: therapeutic implications. Mol Cancer Ther. 2016;15:1781\u201391.","journal-title":"Mol Cancer Ther"},{"key":"1988_CR17","doi-asserted-by":"crossref","unstructured":"Lesueur F, Easton DF, Renault A-L, T SV, B JL, K-J Z, et al. First international workshop of the ATM and cancer risk group (4\u20135 December 2019). Fam Cancer. 2022;21:211\u201327.","DOI":"10.1007\/s10689-021-00248-y"},{"key":"1988_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-018-0951-9","volume":"20","author":"A-L Renault","year":"2018","unstructured":"Renault A-L, Mebirouk N, Fuhrmann L, Bataillon G, Cavaciuti E, Le Gal D, et al. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers. Breast Cancer Res. 2018;20:1\u201318.","journal-title":"Breast Cancer Res"},{"key":"1988_CR19","doi-asserted-by":"crossref","unstructured":"Weigelt B, Bi R, Kumar R, Blecua P, M DL, G FC, et al. The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers. JNCI: J Natl Cancer Inst. 2018;110:1030\u20134.","DOI":"10.1093\/jnci\/djy028"},{"key":"1988_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41523-021-00360-3","volume":"7","author":"MC Southey","year":"2021","unstructured":"Southey MC, Dowty JG, Riaz M, Steen JA, Renault A-L, Tucker K, et al. Population-based estimates of breast cancer risk for carriers of pathogenic variants identified by gene-panel testing. NPJ Breast Cancer. 2021;7:153.","journal-title":"NPJ Breast Cancer"},{"key":"1988_CR21","doi-asserted-by":"publisher","first-page":"e216744","DOI":"10.1001\/jamaoncol.2021.6744","volume":"8","author":"N Mavaddat","year":"2022","unstructured":"Breast Cancer Association Consortium, Mavaddat N, Dorling L, Carvalho S, Allen J, Gonz\u00e1lez-Neira A, et al. Pathology of tumors associated with pathogenic germline variants in 9 breast Cancer susceptibility genes. JAMA Oncol. 2022;8:e216744.","journal-title":"JAMA Oncol"},{"key":"1988_CR22","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the catalogue of somatic mutations in Cancer. Nucleic Acids Res. 2019;47:D941\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1988_CR23","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/ng.3934","volume":"49","author":"P Polak","year":"2017","unstructured":"Polak P, Kim J, Braunstein LZ, Tiao G, Karlic R, Rosebrock D, et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat Genet. 2017;49:1476\u201386.","journal-title":"Nat Genet"},{"key":"1988_CR24","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1128\/MCB.01597-12","volume":"33","author":"A Shamma","year":"2013","unstructured":"Shamma A, Suzuki M, Hayashi N, Kobayashi M, Sasaki N, Nishiuchi T, et al. ATM mediates pRB function to control DNMT1 protein stability and DNA methylation. Mol Cell Biol. 2013;33:3113\u201324.","journal-title":"Mol Cell Biol"},{"key":"1988_CR25","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/sj.bjc.6690460","volume":"80","author":"N Janin","year":"1999","unstructured":"Janin N, Andrieu N, Ossian K, Lauge A, Croquette MF, Griscelli C, et al. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer. 1999;80:1042\u20135.","journal-title":"Br J Cancer"},{"key":"1988_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gcc.20101","volume":"42","author":"E Cavaciuti","year":"2005","unstructured":"Cavaciuti E, Lauge A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, et al. Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families. Genes Chromosom Cancer. 2005;42:1\u20139.","journal-title":"Genes Chromosom Cancer"},{"key":"1988_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/carcin\/bgx074","volume":"38","author":"A-L Renault","year":"2017","unstructured":"Renault A-L, Mebirouk N, Cavaciuti E, Le Gal D, Lecarpentier J, d\u2019Enghien CD, et al. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families. Carcinogenesis. 2017;38:994\u20131003.","journal-title":"Carcinogenesis"},{"key":"1988_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12885-015-2028-9","volume":"16","author":"OM Sinilnikova","year":"2016","unstructured":"Sinilnikova OM, Dondon M-G, Eon-Marchais S, Damiola F, Barjhoux L, Marcou M, et al. GENESIS: a French National resource to study the missing heritability of breast cancer. BMC Cancer. 2016;16:13.","journal-title":"BMC Cancer"},{"key":"1988_CR29","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1186\/bcr801","volume":"6","author":"EM John","year":"2004","unstructured":"John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The breast Cancer family registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res. 2004;6:R375\u2013389.","journal-title":"Breast Cancer Res"},{"key":"1988_CR30","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/ije\/dyx085","volume":"46","author":"RL Milne","year":"2017","unstructured":"Milne RL, Fletcher AS, MacInnis RJ, Hodge AM, Hopkins AH, Bassett JK, et al. Cohort profile: the Melbourne collaborative cohort study (Health 2020). Int J Epidemiol. 2017;46:1757\u2013i1757.","journal-title":"Int J Epidemiol"},{"key":"1988_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/95.6.448","volume":"95","author":"GS Dite","year":"2003","unstructured":"Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MRE, et al. Familial risks, Early-Onset breast cancer, and BRCA1 and BRCA2 germline mutations. JNCI J Natl Cancer Inst. 2003;95:448\u201357.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"1988_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13058-022-01518-y","volume":"24","author":"A-L Renault","year":"2022","unstructured":"Renault A-L, Dowty JG, Steen JA, Li S, Winship IM, Giles GG, et al. Population-based estimates of age-specific cumulative risk of breast cancer for pathogenic variants in ATM. Breast Cancer Res. 2022;24:24.","journal-title":"Breast Cancer Res"},{"key":"1988_CR33","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47:D886\u201394.","journal-title":"Nucleic Acids Res"},{"key":"1988_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s13104-015-1487-z","volume":"8","author":"EM Wong","year":"2015","unstructured":"Wong EM, Joo JE, McLean CA, Baglietto L, English DR, Severi G, et al. Tools for translational epigenetic studies involving formalin-fixed paraffin-embedded human tissue: applying the infinium HumanMethyation450 Beadchip assay to large population-based studies. BMC Res Notes. 2015;8:543.","journal-title":"BMC Res Notes"},{"key":"1988_CR35","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive bioconductor package for the analysis of infinium DNA methylation microarrays. Bioinformatics. 2014;30:1363\u20139.","journal-title":"Bioinformatics"},{"key":"1988_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"Y Chen","year":"2013","unstructured":"Chen Y, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-reactive probes and polymorphic CpGs in the illumina infinium HumanMethylation450 microarray. Epigenetics. 2013;8:203\u20139.","journal-title":"Epigenetics"},{"key":"1988_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley R, Zotenko E, Peters TJ, Lawrence MG, Risbridger GP, Molloy P, et al. Critical evaluation of the illumina methylationepic BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17:208.","journal-title":"Genome Biol"},{"key":"1988_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0503-2","volume":"15","author":"J-P Fortin","year":"2014","unstructured":"Fortin J-P, Labbe A, Lemire M, Zanke BW, Hudson TJ, Fertig EJ, et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 2014;15:1\u201317.","journal-title":"Genome Biol"},{"key":"1988_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2105-11-587","volume":"11","author":"P Du","year":"2010","unstructured":"Du P, Zhang X, Huang C-C, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587.","journal-title":"BMC Bioinformatics"},{"key":"1988_CR40","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841\u20132.","journal-title":"Bioinformatics"},{"key":"1988_CR41","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomart. Nat Protoc. 2009;4:1184\u201391.","journal-title":"Nat Protoc"},{"key":"1988_CR42","unstructured":"Konopka T. umap: Uniform Manifold Approximation and Projection. 2020 [cited 2021 Jun 25]. Available from: https:\/\/CRAN.R-project.org\/package=umap"},{"key":"1988_CR43","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47\u201347.","journal-title":"Nucleic Acids Res"},{"key":"1988_CR44","doi-asserted-by":"crossref","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple hypothesis testing. J R Stat Soc B. 1995;57.","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"1988_CR45","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences. 2005;102:15545\u201350.","DOI":"10.1073\/pnas.0506580102"},{"key":"1988_CR46","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (N Y). 2021;2:100141.","journal-title":"Innov (N Y)"},{"key":"1988_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"1988_CR48","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28:1947\u201351.","journal-title":"Protein Sci"},{"key":"1988_CR49","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587\u201392.","journal-title":"Nucleic Acids Res"},{"key":"1988_CR50","doi-asserted-by":"publisher","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","volume":"5","author":"D Merico","year":"2010","unstructured":"Merico D, Isserlin R, Stueker O, Emili A, Bader GD. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS ONE. 2010;5:e13984.","journal-title":"PLoS ONE"},{"key":"1988_CR51","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"1988_CR52","doi-asserted-by":"publisher","unstructured":"Chen T, Guestrin C, XGBoost:. A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. San Francisco California USA: ACM; 2016 [cited 2024 Aug 8]. pp. 785\u201394. Available from: https:\/\/doi.org\/10.1145\/2939672.2939785","DOI":"10.1145\/2939672.2939785"},{"key":"1988_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12864-019-6413-7","volume":"21","author":"D Chicco","year":"2020","unstructured":"Chicco D, Jurman G. The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation. BMC Genomics. 2020;21:6.","journal-title":"BMC Genomics"},{"key":"1988_CR54","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci. 1971;68:820\u20133.","journal-title":"Proc Natl Acad Sci"},{"key":"1988_CR55","doi-asserted-by":"publisher","first-page":"9432","DOI":"10.1038\/sj.onc.1208092","volume":"23","author":"QN Vo","year":"2004","unstructured":"Vo QN, Kim W-J, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD. The ATM gene is a target for epigenetic Silencing in locally advanced breast cancer. Oncogene. 2004;23:9432\u20137.","journal-title":"Oncogene"},{"key":"1988_CR56","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/bjc.2015.60","volume":"112","author":"S Rondeau","year":"2015","unstructured":"Rondeau S, Vacher S, De Koning L, Briaux A, Schnitzler A, Chemlali W, et al. ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels. Br J Cancer. 2015;112:1059\u201366.","journal-title":"Br J Cancer"},{"key":"1988_CR57","first-page":"3003","volume":"18","author":"N Begam","year":"2017","unstructured":"Begam N, Jamil K, Raju SG. Promoter hypermethylation of the ATM gene as a novel biomarker for breast Cancer. Asian Pac J Cancer Prev. 2017;18:3003\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1988_CR58","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12864-015-1994-2","volume":"16","author":"M Moarii","year":"2015","unstructured":"Moarii M, Boeva V, Vert J-P, Reyal F. Changes in correlation between promoter methylation and gene expression in cancer. BMC Genomics. 2015;16:873.","journal-title":"BMC Genomics"},{"key":"1988_CR59","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/1471-2407-11-332","volume":"11","author":"VD Haakensen","year":"2011","unstructured":"Haakensen VD, Bj\u00f8ro T, L\u00fcders T, Riis M, Bukholm IK, Kristensen VN, et al. Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas. BMC Cancer. 2011;11:332.","journal-title":"BMC Cancer"},{"key":"1988_CR60","doi-asserted-by":"crossref","unstructured":"Zhang P, Chen T, Yang M. Comparative analysis of prognosis and gene expression in prostate cancer patients with site-specific visceral metastases. Urologic Oncology: Seminars and Original Investigations. 2024;42:160.e1-160.e10.","DOI":"10.1016\/j.urolonc.2024.01.032"},{"key":"1988_CR61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1479-5876-8-86","volume":"8","author":"M Castro","year":"2010","unstructured":"Castro M, Grau L, Puerta P, Gimenez L, Venditti J, Quadrelli S, et al. Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med. 2010;8:86.","journal-title":"J Transl Med"},{"key":"1988_CR62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13277-011-0266-2","volume":"33","author":"Y Yu","year":"2012","unstructured":"Yu Y, Yin D, Hoque MO, Cao B, Jia Y, Yang Y, et al. AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer. Tumour Biol. 2012;33:307\u201314.","journal-title":"Tumour Biol"},{"key":"1988_CR63","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/1541-7786.489.2.9","volume":"2","author":"I Krop","year":"2004","unstructured":"Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, et al. Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol Cancer Res. 2004;2:489\u201394.","journal-title":"Mol Cancer Res"},{"key":"1988_CR64","doi-asserted-by":"publisher","first-page":"8209","DOI":"10.1007\/s13277-014-2055-1","volume":"35","author":"D Dai","year":"2014","unstructured":"Dai D, Dong X-H, Cheng S-T, Zhu G, Guo X-L. Aberrant promoter methylation of HIN-1 gene May contribute to the pathogenesis of breast cancer: a meta-analysis. Tumour Biol. 2014;35:8209\u201316.","journal-title":"Tumour Biol"},{"key":"1988_CR65","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/15592294.2016.1192735","volume":"11","author":"CL Callahan","year":"2016","unstructured":"Callahan CL, Wang Y, Marian C, Weng DY, Eng KH, Tao M-H, et al. DNA methylation and breast tumor clinicopathological features: the Western new York exposures and breast Cancer (WEB) study. Epigenetics. 2016;11:643\u201352.","journal-title":"Epigenetics"},{"key":"1988_CR66","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s43042-021-00185-6","volume":"22","author":"AM Nomair","year":"2021","unstructured":"Nomair AM, Ahmed SS, Mohammed AF, El Mansy H, Nomeir HM. SCGB3A1 gene DNA methylation status is associated with breast cancer in Egyptian female patients. Egypt J Med Hum Genet. 2021;22:66.","journal-title":"Egypt J Med Hum Genet"},{"key":"1988_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13058-017-0814-9","volume":"19","author":"DJ Lemler","year":"2017","unstructured":"Lemler DJ, Lynch ML, Tesfay L, Deng Z, Paul BT, Wang X, et al. DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms. Breast Cancer Res. 2017;19:25.","journal-title":"Breast Cancer Res"},{"key":"1988_CR68","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1111\/exd.14950","volume":"32","author":"N Yu","year":"2023","unstructured":"Yu N, Yuan B, Cai J, Liu J, Zhang W, Bao W, et al. Loss of ARHGAP40 expression in basal cell carcinoma via CpG Island hypermethylation. Exp Dermatol. 2023;32:2094\u2013101.","journal-title":"Exp Dermatol"},{"key":"1988_CR69","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/ijms19030693","volume":"19","author":"M Busby","year":"2018","unstructured":"Busby M, Hallett MT, Plante I. The complex Subtype-Dependent role of connexin 43 (GJA1) in breast Cancer. Int J Mol Sci. 2018;19:693.","journal-title":"Int J Mol Sci"},{"key":"1988_CR70","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.2147\/CMAR.S235500","volume":"12","author":"W Hu","year":"2020","unstructured":"Hu W, Li S, Zhang S, Xie B, Zheng M, Sun J, et al. GJA1 is a prognostic biomarker and correlated with immune infiltrates in colorectal Cancer. Cancer Manage Res. 2020;12:11649\u201361.","journal-title":"Cancer Manage Res"},{"key":"1988_CR71","doi-asserted-by":"publisher","first-page":"e8827920","DOI":"10.1155\/2020\/8827920","volume":"2020","author":"S Meng","year":"2020","unstructured":"Meng S, Fan X, Zhang J, An R, Li S. GJA1 expression and its prognostic value in cervical Cancer. Biomed Res Int. 2020;2020:e8827920.","journal-title":"Biomed Res Int"},{"key":"1988_CR72","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s40478-018-0642-x","volume":"6","author":"Y Kajiwara","year":"2018","unstructured":"Kajiwara Y, Wang E, Wang M, Sin WC, Brennand KJ, Schadt E, et al. GJA1 (connexin43) is a key regulator of Alzheimer\u2019s disease pathogenesis. Acta Neuropathol Commun. 2018;6:144.","journal-title":"Acta Neuropathol Commun"},{"key":"1988_CR73","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1038\/sj.onc.1209873","volume":"25","author":"M Ahmed","year":"2006","unstructured":"Ahmed M, Rahman N. ATM and breast cancer susceptibility. Oncogene. 2006;25:5906\u201311.","journal-title":"Oncogene"},{"key":"1988_CR74","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford AN, Jackson SP. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol Cell. 2017;66:801\u201317.","journal-title":"Mol Cell"},{"key":"1988_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-57362-1_1","volume":"217","author":"JT Schiller","year":"2021","unstructured":"Schiller JT, Lowy DR. An introduction to virus infections and human Cancer. Recent Results Cancer Res. 2021;217:1\u201311.","journal-title":"Recent Results Cancer Res"},{"key":"1988_CR76","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/cells9091969","volume":"9","author":"L Pizzamiglio","year":"2020","unstructured":"Pizzamiglio L, Focchi E, Antonucci F. ATM protein kinase: old and new implications in neuronal pathways and brain circuitry. Cells. 2020;9:1969.","journal-title":"Cells"},{"key":"1988_CR77","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/dvdy.24522","volume":"247","author":"KR Choy","year":"2018","unstructured":"Choy KR, Watters DJ. Neurodegeneration in ataxia-telangiectasia: multiple roles of ATM kinase in cellular homeostasis. Dev Dyn. 2018;247:33\u201346.","journal-title":"Dev Dyn"},{"key":"1988_CR78","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370.","journal-title":"Nature"},{"key":"1988_CR79","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/bs.adgen.2015.11.004","volume":"93","author":"YV Sun","year":"2016","unstructured":"Sun YV, Hu Y-J. Integrative analysis of Multi-omics data for discovery and functional studies of complex human diseases. Adv Genet. 2016;93:147\u201390.","journal-title":"Adv Genet"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-01988-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-01988-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-01988-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:07:36Z","timestamp":1741705656000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-025-01988-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1988"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-01988-w","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CoFAT2 and GENESIS: Written informed consent for genetic studies and use of medical records for the present analyses was obtained from all participants. The appropriate local ethics committee (Comit\u00e9 de Protection des Personnes [CCP] Ile-de-France III 2002\/2006) and the French data protection authority (Commission Nationale de l\u2019Informatique et des Libert\u00e9s [CNIL]) approved the study protocols CoF-AT2 and GENESIS, the individual resource collections, and the specific study on tumor material. MCCS: Written informed consent was obtained from all participants to collect a blood sample and tumor pathology materials. The study protocols were approved by Human Research Ethics Committee at the Cancer Council Victoria (MCCS). ABCFS: The study was approved by the Human Research Ethics Committee of the University of Melbourne (12496). Informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}